Wiener Renda Soylemez, Slatore Christopher G, Gillespie Chris, Clark Jack A
Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial VA Hospital, Bedford, MA; Pulmonary Center, Department of Medicine, Oregon Health and Science University, Portland, OR.
Health Services Research and Development, Department of Medicine, Oregon Health and Science University, Portland, OR; Section of Pulmonary and Critical Care Medicine, VA Portland Health Care System, Portland, OR; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, OR.
Chest. 2015 Dec;148(6):1415-1421. doi: 10.1378/chest.14-2941.
Selecting a strategy (surveillance, biopsy, resection) for pulmonary nodule evaluation can be complex given the absence of high-quality data comparing strategies and the important tradeoffs among strategies. Guidelines recommend a three-step approach: (1) assess the likelihood of malignancy, (2) evaluate whether the patient is a candidate for invasive intervention, and (3) elicit the patient's preferences and engage in shared decision-making. We sought to characterize how pulmonologists select a pulmonary nodule evaluation strategy and the extent to which they report following the guideline-recommended approach.
We conducted semistructured qualitative interviews with 14 pulmonologists who manage patients with pulmonary nodules at four clinical sites. Transcripts of audiorecorded interviews were analyzed using the principles of grounded theory.
Pulmonologists reported consistently performing steps 1 and 2 but described diverse approaches to step 3 that ranged from always engaging the patient in decision-making to never doing so. Many described incorporating patients' preferences only in particular circumstances, such as when the patient appeared particularly anxious or was aggressive in questioning management options. Indeed, other factors, including convenience, physician preferences, physician anxiety, malpractice concerns, and physician experience, appeared to drive decision-making as much as, if not more than, patient preferences.
Although pulmonologists appear to routinely personalize pulmonary nodule evaluation strategies based on the individual patient's risk-benefit tradeoffs, they may not consistently take patient preferences into account during the decision-making process. In the absence of high-quality evidence regarding the optimal methods of pulmonary nodule evaluation, physicians should strive to ensure that management decisions are consistent with patients' values.
鉴于缺乏比较不同策略的高质量数据以及各策略之间重要的权衡取舍,选择一种用于肺结节评估的策略(监测、活检、切除)可能会很复杂。指南推荐一种三步法:(1)评估恶性肿瘤的可能性,(2)评估患者是否适合进行侵入性干预,(3)了解患者的偏好并参与共同决策。我们试图描述肺科医生如何选择肺结节评估策略以及他们遵循指南推荐方法的程度。
我们对四个临床地点负责管理肺结节患者的14位肺科医生进行了半结构化定性访谈。使用扎根理论原则对录音访谈的文字记录进行了分析。
肺科医生报告始终执行步骤1和步骤2,但描述了步骤3的不同方法,范围从总是让患者参与决策到从不这样做。许多人描述仅在特定情况下纳入患者的偏好,例如当患者显得特别焦虑或积极质疑管理方案时。事实上,其他因素,包括便利性、医生偏好、医生焦虑、医疗事故担忧和医生经验,似乎在决策中起到的推动作用与患者偏好一样大,甚至更大。
尽管肺科医生似乎通常根据个体患者的风险效益权衡来个性化肺结节评估策略,但他们在决策过程中可能并非始终考虑患者的偏好。在缺乏关于肺结节评估最佳方法的高质量证据的情况下,医生应努力确保管理决策与患者的价值观一致。